The pathogenesis of this RA subset is less well understood than the anti-CCP-positive RA subset [5], though there are reports that anti-CCP-positive RA patients experience longer disease duration [21], higher acute-phase reactants, short-term radiographic progression [22], and a reduced response to anti-TNF treatment [23]. This evidence concerns the gene TNF and rheumatoid arthritis.